These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Nonparametric estimation of duration of accrual and total study length for clinical trials. Morgan TM Biometrics; 1987 Dec; 43(4):903-12. PubMed ID: 3427175 [TBL] [Abstract][Full Text] [Related]
23. Public Health Service--Grants for allied health projects. Final rule. Fed Regist; 1980 Jul; 45(141):48623-6. PubMed ID: 10247437 [TBL] [Abstract][Full Text] [Related]
24. Modelling clinical trials in heterogeneous samples. Liu W; Zhao W; Shaffer ML; Icitovic N; Chase GA Stat Med; 2005 Sep; 24(18):2765-75. PubMed ID: 16007572 [TBL] [Abstract][Full Text] [Related]
25. Perspectives on clinical outcomes assessment: a view for the allied health professions. Pfeifle WG; Gussak DE; Keegan CA J Allied Health; 1999; 28(4):240-6. PubMed ID: 10614557 [TBL] [Abstract][Full Text] [Related]
26. Estimating treatment effects in clinical trials subject to regression to the mean. Senn SJ; Brown RA Biometrics; 1985 Jun; 41(2):555-60. PubMed ID: 4027329 [No Abstract] [Full Text] [Related]
27. A new player on the allied health team: the clinical health educator. Zimering S; McTernan EJ J Allied Health; 1975; 4(3):27-30. PubMed ID: 10237905 [No Abstract] [Full Text] [Related]
28. Allied health perspectives in the 1980s. Holder L J Allied Health; 1981 Feb; 10(1):5-14. PubMed ID: 7228818 [TBL] [Abstract][Full Text] [Related]
29. Treatment allocation for nonlinear models in clinical trials: the logistic model. Begg CB; Kalish LA Biometrics; 1984 Jun; 40(2):409-20. PubMed ID: 6487725 [TBL] [Abstract][Full Text] [Related]
30. Providing continuing education opportunities in the allied health professions. Smorynski HW; Parochka J J Allied Health; 1979 Feb; 8(1):47-54. PubMed ID: 10240593 [TBL] [Abstract][Full Text] [Related]
31. [Some proposals to cancer clinical trials in Japan--a biostatistician's view]. Oh-hashi Y Gan To Kagaku Ryoho; 1993 Dec; 20(16):2483-95. PubMed ID: 8279846 [No Abstract] [Full Text] [Related]
32. Continuous toxicity monitoring in phase II trials in oncology. Ivanova A; Qaqish BF; Schell MJ Biometrics; 2005 Jun; 61(2):540-5. PubMed ID: 16011702 [TBL] [Abstract][Full Text] [Related]
33. Curricular implications of health promotion and disease prevention in allied health education. Bunker JF; Parcel GS; Phillips BU; Simons-Morton D J Allied Health; 1986 Nov; 15(4):329-37. PubMed ID: 3793611 [TBL] [Abstract][Full Text] [Related]
34. New principles of biometry 'not being observed'. Rahlfs VW Int J Clin Pract; 1997 Oct; 51(7):480. PubMed ID: 9536595 [No Abstract] [Full Text] [Related]
35. [Future-oriented clinical research in Germany. Biostatistics]. Forst HT Dtsch Med Wochenschr; 1999 Oct; 124(39):A15-20. PubMed ID: 10576969 [No Abstract] [Full Text] [Related]
36. Exact significance testing to establish treatment equivalence with ordered categorical data. Mehta CR; Patel NR; Tsiatis AA Biometrics; 1984 Sep; 40(3):819-25. PubMed ID: 6518249 [TBL] [Abstract][Full Text] [Related]
37. [Evaluation of the effectiveness of medical treatment of intermittent claudication]. Serradimigni A; Jouve R; Spriet A J Mal Vasc; 1985; 10(2):108-16. PubMed ID: 3903016 [TBL] [Abstract][Full Text] [Related]
38. Planning and monitoring of equivalence studies. Durrleman S; Simon R Biometrics; 1990 Jun; 46(2):329-36. PubMed ID: 2194579 [TBL] [Abstract][Full Text] [Related]
39. Accreditation, core curriculum and allied health education: barriers and opportunities. Gelmon SB J Allied Health; 1997; 26(3):119-25. PubMed ID: 9358302 [TBL] [Abstract][Full Text] [Related]